Anemia Clinical Trial
Some micronutrients are likely to interact with malaria parasite, leading to either
synergistic or antagonist effect on malaria morbidity and therefore on hemoglobin response.
The purpose of this study is to investigate the effect of supplementation with iron or
multiple micronutrients on anemia while integrated with malaria management in rural
Burkinabe young anemic children with high prevalence of malaria.
This is a community-based randomised double-blind trial. Children aged 6-23 months are
randomised to receive either iron (n=91), iron and zinc (IZ, n=90) or MMN (n=89), 5
days/week for 6 months. Supplements are manufactured by Nutriset (Malaunay, France) as
specifically fortified "plumpy-nut". They are presented in 90 ml boxes coded A, B and C each
lot of boxes contained in white packing labelled A, B and C respectively. Malaria is managed
in concordance with the national malaria program standards. All mothers receive one
insecticide-treated bed-net (PermaNet®, Vestergaard Frandsen Disease Control Textiles) and
instruction for effective utilization for children. All children with positive smear for
Plasmodium falciparum are artemether+lumefantrine-treated (Coartem®, Novartis Pharma S.A.S.,
France) regardless of the clinical status. Children aged of at least 12 months receive 200
mg albendazole, one week prior to the supplementation starting.
Data collection involves:
- a questionnaire addressed to mothers at baseline,
- a medical examination of mothers and children at baseline: A general practitioner
examines mothers for goiter determination according to the International Council for
the Control of Iodine Deficiency Disorders (ICCIDD) definition and classification, and
children for splenomegaly that is classified according to Hackett. Anthropometrical
measurements are performed on children and mothers by a nutritionist, in agreement with
the WHO recommendations. Children's capillary blood is obtained by lab technicians
through a finger stick for hemoglobin measurement and malaria blood smear preparation.
Hemoglobin is measured using a HemoCue® machine (Hemocue HB 201+, Angelholm, Sweden) to
the nearest 1g/L.
- malaria microscopic detection at baseline and monthly during the study: blood smears
intending to detect malaria infection are stained with Giemsa, and read in duplicate at
the local hospital laboratory,
- a daily record of supplementation and morbidity data (diarrhoea, fever, cough).
The endpoints considered for analysis are change of hemoglobin (final haemoglobin minus
baseline haemoglobin concentration) and final anemia status that are analysed by multiple
linear regression and logistic regression respectively.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |